Clover Health Investments, Corp. CLOV · SEC Filings

website

724

Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. ...

Price4.83

Market Cap2.57 B

Float410.46 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

8-K

Clover Health Reports Third Quarter 2026 Results and Raises Full Year 2026 Guidance

Nov 4, 2026

8-K

Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027

Oct 8, 2026

8-K/A

Former Senator Robert Torricelli and Dr. Brian J. Miller Appointed to Board, Filling Two Vacancies and Expanding Membership to Nine Directors

Sep 24, 2026

8-K

Clover Health Appoints Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller to Board of Directors

Sep 24, 2026

8-K

Clover Health (Nasdaq: CLOV) Second Quarter 2026 Supplemental Q&A

Aug 20, 2026

8-K

Clover Health Reports Strong Second Quarter 2026 Results and Raises Full-Year Guidance

Aug 5, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

UPDATED

Jan 19, 2022

424B4

OFFERING | Shares amount: 52,173,913 | Share price: $5.75 | Offering amount: $299,999,999.75

Nov 18, 2021

424B3

UPDATED

Nov 9, 2021

424B3

UPDATED

Sep 14, 2021

424B3

UPDATED

Aug 25, 2021

424B3

UPDATED

Aug 13, 2021

Registrations

TYPE

HEADLINE

FILED AT

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 28, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 28, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 28, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 28, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 26, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 26, 2024

Ownerships

TYPE

HEADLINE

FILED AT

OLDAKOWSKI JOSEPH FRANK (Reporting)

Nov 6, 2026

THORNTON JOSEPH CLAY (Reporting)

Nov 6, 2026

Soares Karen (Reporting)

Oct 20, 2026

Reynoso Jamie L. (Reporting)

Oct 20, 2026

144

Form 144 - Report of proposed sale of securities

Oct 20, 2026

Toy Andrew (Reporting)

Oct 19, 2026

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

Dec 15, 2022

CORRESP

Form CORRESP - Correspondence

Nov 22, 2022

LETTER

Form UPLOAD - SEC-generated letter

Nov 9, 2022

CORRESP

Form CORRESP - Correspondence

Sep 28, 2022

LETTER

Form UPLOAD - SEC-generated letter

Sep 9, 2022

EFFECT

Form EFFECT - Notice of Effectiveness

May 23, 2022